BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 1368020)

  • 1. Ribozymes.
    Rossi JJ
    Curr Opin Biotechnol; 1992 Feb; 3(1):3-7. PubMed ID: 1368020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of imperfectly paired helices I and III on the catalytic activity of hammerhead ribozymes.
    Zoumadakis M; Neubert WJ; Tabler M
    Nucleic Acids Res; 1994 Dec; 22(24):5271-8. PubMed ID: 7816616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hammerhead ribozymes: biochemical and chemical considerations.
    Goodchild J
    Curr Opin Mol Ther; 2000 Jun; 2(3):272-81. PubMed ID: 11249621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hammerhead ribozymes targeted to the FBN1 mRNA can discriminate a single base mismatch between ribozyme and target.
    Phylactou LA; Tsipouras P; Kilpatrick MW
    Biochem Biophys Res Commun; 1998 Aug; 249(3):804-10. PubMed ID: 9731217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A three-nucleotide helix I is sufficient for full activity of a hammerhead ribozyme: advantages of an asymmetric design.
    Tabler M; Homann M; Tzortzakaki S; Sczakiel G
    Nucleic Acids Res; 1994 Sep; 22(19):3958-65. PubMed ID: 7937118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic selectivity of complementary nucleic acids: bcr-abl-directed antisense RNA and ribozymes.
    Kronenwett R; Haas R; Sczakiel G
    J Mol Biol; 1996 Jun; 259(4):632-44. PubMed ID: 8683570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Length variation of helix III in a hammerhead ribozyme and its influence on cleavage activity.
    Hammann C; Martinez E; Moosbauer J; Hormes R; Tabler M
    Antisense Nucleic Acid Drug Dev; 1999 Feb; 9(1):25-31. PubMed ID: 10192286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic applications of catalytic antisense RNAs (ribozymes).
    Rossi JJ
    Ciba Found Symp; 1997; 209():195-204; discussion 204-6. PubMed ID: 9383577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribozymes of the hepatitis delta virus: recent findings on their structure, mechanism of catalysis and possible applications.
    Ciesiolka J; Wrzesinski J; Legiewicz M; Smólska B; Dutkiewicz M
    Acta Biochim Pol; 2001; 48(2):409-18. PubMed ID: 11732611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribozymes: stop making sense.
    Edgington SM
    Biotechnology (N Y); 1992 Mar; 10(3):256-62. PubMed ID: 1374263
    [No Abstract]   [Full Text] [Related]  

  • 11. Structure-function relationships of hammerhead ribozymes: from understanding to applications.
    Sigurdsson ST; Eckstein F
    Trends Biotechnol; 1995 Aug; 13(8):286-9. PubMed ID: 7662303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribozymes: from mechanistic studies to applications in vivo.
    Ohkawa J; Koguma T; Kohda T; Taira K
    J Biochem; 1995 Aug; 118(2):251-8. PubMed ID: 8543555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 TAR as anchoring site for optimized catalytic RNAs.
    Puerta-Fernandez E; Barroso-del Jesus A; Romero-López C; Berzal-Herranz A
    Biol Chem; 2003 Mar; 384(3):343-50. PubMed ID: 12715885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and function of the hairpin ribozyme.
    Fedor MJ
    J Mol Biol; 2000 Mar; 297(2):269-91. PubMed ID: 10715200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of hairpin ribozyme cleavage in yeast.
    Donahue CP; Fedor MJ
    RNA; 1997 Sep; 3(9):961-73. PubMed ID: 9292496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient trans cleavage and a common structural motif for the ribozymes of the human hepatitis delta agent.
    Branch AD; Robertson HD
    Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10163-7. PubMed ID: 1946436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PCR-based construction of long hammerhead ribozymes.
    Zillmann M; Robinson G
    Methods Mol Biol; 1997; 74():131-9. PubMed ID: 9204428
    [No Abstract]   [Full Text] [Related]  

  • 18. Anchoring hairpin ribozymes to long target RNAs by loop-loop RNA interactions.
    Puerta-Fernández E; Barroso-DelJesus A; Berzal-Herranz A
    Antisense Nucleic Acid Drug Dev; 2002 Feb; 12(1):1-9. PubMed ID: 12022685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One sequence, two ribozymes: implications for the emergence of new ribozyme folds.
    Schultes EA; Bartel DP
    Science; 2000 Jul; 289(5478):448-52. PubMed ID: 10903205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and production of asymmetric hammerhead ribozymes.
    Tabler M; Sczakiel G
    Methods Mol Biol; 1997; 74():141-9. PubMed ID: 9204429
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.